Humana Inc. shares rise 3.90% to $223.62, outperforming competitors

10 articles · Updated · MarketWatch · Apr 27

Humana Inc. posted its second consecutive day of gains on Monday, closing at $223.62 with a 3.90% increase.
The stock outperformed UnitedHealth Group and Chubb Ltd., while Elevance Health also saw a 3.30% rise. Trading volume was 1.3 million, below the 50-day average.
Despite recent gains, Humana Inc. remains 29.09% below its 52-week high of $315.35 reached in September 2025, amid a mixed broader market session.

Is Humana's aggressive enrollment growth a risky gamble while competitors shrink to protect profits?

How does the partnership with Mark Cuban's company change prescription costs for the average Humana member?

Can Humana's CenterWell expansion offset billions in lost revenue from its looming Star Ratings cliff?

Will rising medical costs erase the expected margin recovery for health insurers despite favorable new MA rates?

Will the Trump administration's overhaul of Medicare star ratings actually improve care or just inflate insurer profits?

How will the new 10-year federal ACO model reshape the future of value-based healthcare?